CHM, I've noticed CTIX has a tendency toward that type of breathless headline. It's good timing if they're about to raise some cash, but I don't like seeing a company use hype routinely.
But perhaps this really is a significant development(?) I haven't researched their non-Brilacidin programs much since they're so early stage, but I'll be curious to read any comments over on Dew's board. Someone just posted the CTIX press release over there -